Related Experiment Videos
Natural killer cell response to regional lymph node metastases
Archives of Otolaryngology--Head & Neck Surgery
|May 1, 1986
Summary
Natural killer cell activity is higher in advanced head and neck cancer patients without lymph node metastases. Extranodal cancer significantly increases natural killer cell cytotoxicity in patients with lymph node involvement.
Area of Science:
- Immunology
- Oncology
Background:
- Advanced head and neck cancer is associated with complex immune responses.
- Natural killer (NK) cells play a crucial role in anti-tumor immunity.
Purpose of the Study:
- To investigate natural killer cell activity in patients with advanced head and neck cancer.
- To determine the correlation between NK cell activity and cancer staging, particularly nodal involvement and extranodal extension.
Main Methods:
- Natural killer cell activity was measured in 67 individuals with advanced head and neck cancer.
- Patients were stratified based on clinical staging (TNM system), including nodal status (N0, palpable metastases, fixed/adherent nodes).
- Cytotoxicity was quantified in lytic units (LU).
Main Results:
- Patients staged T3 N0 or T4 N0 (no palpable lymph nodes) exhibited significantly higher NK cell activity (81 ± 11 LU) compared to those with palpable lymph node metastases (54 ± 5 LU).
- NK cell activity showed a non-significant trend of increase with progressive N-staging.
- Extranodal cancer extension, indicated by tumor fixation or skin adherence, was associated with significantly higher NK cell activity (87 ± 15 LU) compared to regional nodal disease without fixation (45 ± 4 LU).
Conclusions:
- Natural killer cell activity is significantly modulated by the extent of disease in advanced head and neck cancer.
- The presence of extranodal extension is a key factor associated with increased NK cell cytotoxicity.
- These findings suggest potential clinical implications for immunotherapy and prognosis in head and neck cancer patients.